Sheppard Mullin expands practice with Perkins Coie trio
Three seasoned lawyers with experience in biotech, pharmaceutical, and medical device patent matters join the firm's practice in Washington, DC and Chicago offices.
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.
For more information on individual annual subscriptions for full paid access and corporate subscription options please contact us.
To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Atif Choudhury at achoudhury@lifesciencesipreview.com
23 June 2026 The pair bring a strong track record advising life sciences companies on licensing, collaboration and commercialisation agreements, with a particular focus on cross-border biotech transactions.
15 June 2026 Highly experienced partner is the second big name to join the firm this year, expanding its Engineering & Tech practice and beefing up its IP disputes work.
11 June 2026 The opportunity to grow a “powerhouse IP litigation practice in the heart of New York” was behind the lateral move of highly experienced litigators to Morrison Foerster.